Caricamento...
Ingenol mebutate in low amounts for the treatment of actinic keratosis in Korean patients
BACKGROUND: Ingenol mebutate (IM), a novel agent for field therapy of actinic keratosis (AK), has a drawback of inducing local skin reactions (LSRs), which may cause discomfort in patients. To reduce the LSRs, we tried the application of IM in low amounts. OBJECTIVE: The purpose of this study was to...
Salvato in:
| Pubblicato in: | Clin Cosmet Investig Dermatol |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove Medical Press
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5384689/ https://ncbi.nlm.nih.gov/pubmed/28408848 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CCID.S129072 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|